Search - tctmd.com

Displaying 61 - 80 of 87

Sort: Relevancy | Date

Video

» Interview

EDIT-CMD Randomized Clinical Trial: Efficacy Of Diltiazem To Improve Coronary Vasomotor Dysfunction In Angina And Nonobstructive Coronary Arteries

May 4, 2022

Video

» Interview

APOLLO Trial: Magnitude And Duration of Effects of A Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial

May 4, 2022

Video

» Interview

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

May 4, 2022

Video

» Interview

"Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Results of the VALOR Trial"

May 4, 2022

Video

» Interview

ACC 2022: PACMAN AMI - Effects Of Alirocumab On Coronary Atherosclerosis Assessed By Serial Multimodality Intracoronary Imaging In Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial

April 12, 2022

Video

» Interview

ACC 2022: The POISE-3 Trial: Efficacy and Safety of Tranexamic Acid in Patients Undergoing Noncardiac Surgery

April 12, 2022

Video

» Interview

Beyond the Data: FLAVOUR

April 6, 2022

Video

» Interview

Beyond the Data: ADAPT-TAVR

April 6, 2022

Video

» Conference Wrap-Up

ACC 2022 Day 2 Wrap-Up

April 3, 2022

Video

» Interview

Beyond the Data: Perspectives from the Ukrainian Border

April 3, 2022

Video

» Interview

Beyond the Data: PACMAN-AMI

April 3, 2022

Video

» Interview

Beyond the Data: Heart Failure Updates and Key Takeaways

April 3, 2022

Video

» Interview

Beyond the Data: Women’s CV Health Updates

April 3, 2022

Video

» Interview

Beyond the Data: ACS/PCI Updates

April 3, 2022

Video

» Interview

ACC 2022: PACIFIC AF - Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with A-Fib

April 3, 2022

Video

» Interview

ACC 2022: The PROTECT Trial - Very Mild Perioperative Hypothermia Versus Aggressive Warming and Myocardial Injury After Non-Cardiac Surgery

April 3, 2022

Video

» Interview

ACC 2022: The FAME 3 Trial - Quality of Life After Fractional Flow Reserve-guided Stenting Compared with Coronary Bypass Surgery

April 3, 2022

Video

» Interview

ACC 2022: POISE-3: The Effects Of A Hypotension-avoidance Strategy vs A Hypertension-avoidance Strategy In Patients Undergoing Noncardiac Surgery

April 3, 2022

Video

» Interview

ACC 2022: One-year Results of the Clasp TR Study: Transcatheter Treatment of Tricuspid Regurgitation

April 3, 2022

Video

» Interview

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

April 3, 2022

Advertisement

EDIT-CMD Randomized Clinical Trial: Efficacy Of Diltiazem To Improve Coronary Vasomotor Dysfunction In Angina And Nonobstructive Coronary Arteries

APOLLO Trial: Magnitude And Duration of Effects of A Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

"Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Results of the VALOR Trial"

ACC 2022: PACMAN AMI - Effects Of Alirocumab On Coronary Atherosclerosis Assessed By Serial Multimodality Intracoronary Imaging In Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial

ACC 2022: The POISE-3 Trial: Efficacy and Safety of Tranexamic Acid in Patients Undergoing Noncardiac Surgery

Beyond the Data: FLAVOUR

Beyond the Data: ADAPT-TAVR

ACC 2022 Day 2 Wrap-Up

Beyond the Data: Perspectives from the Ukrainian Border

Beyond the Data: PACMAN-AMI

Beyond the Data: Heart Failure Updates and Key Takeaways

Beyond the Data: Women’s CV Health Updates

Beyond the Data: ACS/PCI Updates

ACC 2022: PACIFIC AF - Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with A-Fib

ACC 2022: The PROTECT Trial - Very Mild Perioperative Hypothermia Versus Aggressive Warming and Myocardial Injury After Non-Cardiac Surgery

ACC 2022: The FAME 3 Trial - Quality of Life After Fractional Flow Reserve-guided Stenting Compared with Coronary Bypass Surgery

ACC 2022: POISE-3: The Effects Of A Hypotension-avoidance Strategy vs A Hypertension-avoidance Strategy In Patients Undergoing Noncardiac Surgery

ACC 2022: One-year Results of the Clasp TR Study: Transcatheter Treatment of Tricuspid Regurgitation

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content